Zevra Therapeutics, Inc.
Zevra Therapeutics, Inc. scores highest on Torque (86) and lowest on Anchor (46). Its PosiPenta is 63.08 out of 100, better than most similar companies.
On the Penta Grid this week, Zevra Therapeutics, Inc. is Grid #95 of 837 in the Healthcare sector in United States, and Grid #339 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Zevra Therapeutics, Inc. | 63.08 | 63 | 58 | 62 | 86 | 46 |
| Olema Pharmaceuticals, Inc. | 33.98 | 35 | 24 | 13 | 62 | 36 |
| Gyre Therapeutics, Inc. | 52.87 | 12 | 77 | 57 | 68 | 51 |
| Climb Bio, Inc. | 43.67 | 26 | 35 | 61 | 70 | 27 |
| CorMedix Inc. | 58.56 | 80 | 47 | 50 | 67 | 49 |
| Weave Communications, Inc. | 55.10 | 10 | 79 | 96 | 46 | 45 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 10.80 |
| P/B ratio | 2.71 |
EEarnings
| Trailing EPS | ₹87.14 |
| Forward EPS | ₹101.98 |
NNitro
| Price | 941.47 |
| 52-week high | 1424.04 |
| 52-week low | 758.67 |
| Fall from 52-week high | 33.9% |
TTorque
| Return on equity (ROE) | 34.80% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 0.98 |
| Market cap | ₹5,590 Cr |
| Insider holding | 1.31% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Zevra Therapeutics, Inc.'s PosiPenta score?
Zevra Therapeutics, Inc.'s PosiPenta is 63.08 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Zevra Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Zevra Therapeutics, Inc. is Grid #95 of 837 in the Healthcare sector in United States, and Grid #339 of 4,000 in United States.
Which PosiPenta pillar is strongest for Zevra Therapeutics, Inc.?
Torque (durability), with a score of 86 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Zevra Therapeutics, Inc.?
Anchor (stability and dividends), with a score of 46 out of 100: around the middle of similar companies.
Has Zevra Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 0.87 points, from 62.21 to 63.08.
PositoAI is for research and education only and is not investment advice.